Adverse events of rituximab in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis

BACKGROUND: The adverse events (AEs) of rituximab (RTX) for neuromyelitis optica spectrum disorder (NMOSD) are incompletely understood. AIM: To collate information on the reported the AEs of RTX in NMOSD and assess the quality of evidence. METHODS: PubMed, EMBASE, Web of Science, Cochrane Library, W...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Zhou, Juanping, Li, Yi, Wei, Lili, Xu, Xintong, Zhang, Jianping, Yang, Kehu, Wei, Shihui, Zhang, Wenfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689613/
https://www.ncbi.nlm.nih.gov/pubmed/34950240
http://dx.doi.org/10.1177/17562864211056710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689613/
https://www.ncbi.nlm.nih.gov/pubmed/34950240
http://dx.doi.org/10.1177/17562864211056710

Ejemplares similares